Related Experiment Video
Updated: May 10, 2026

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
Co-infections with hepatitis B and C viruses in human immunodeficiency virus-infected patients in Morocco
K Rebbani1, A Ouladlahsen, A Bensghir
1Virology Unit, Viral Hepatitis Laboratory, Pasteur Institute of Morocco, Casablanca, Morocco.
Insights
This study investigated HIV/hepatitis B virus (HBV) and hepatitis C virus (HCV) co-infections in Morocco. Results show a 10.6% co-infection rate, with specific HBV genotype D and an unusual HCV subtype distribution.
Area of Science:
- * Infectious Diseases
- * Hepatology
- * Virology
Background:
- * Human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) represent significant global public health challenges.
- * Understanding co-infection patterns is crucial for managing HIV-infected populations and preventing viral hepatitis transmission.
Purpose of the Study:
- * To determine the prevalence of HBV and HCV infections in HIV-infected patients in Morocco.
- * To identify the primary circulating HBV and HCV genotypes and subtypes within this cohort.
- * To compare findings with the general population's viral hepatitis strain distribution.
Main Methods:
- * Cross-sectional study involving 503 HIV-infected patients in Morocco.
- * Screening for HBV surface antigen and anti-HCV antibodies.
- * HBV DNA sequencing for genotyping and HCV sequencing for subtyping.
Main Results:
- * A 10.6% prevalence of HIV/hepatitis co-infection was observed.
- * HBV surface antigen positivity was 5.2%, and anti-HCV positivity was 5.4%.
- * Exclusively HBV genotype D (D1 and D7) was identified, consistent with general population data. HCV isolates showed an unusual subtype distribution: 1a and 3a (23.5% each), 1b and 4a (17.6% each), 1c (11.8%), and 6h (6%).
Conclusions:
- * HIV/HBV and HIV/HCV co-infections are prevalent in the studied Moroccan HIV-infected population.
- * HBV strains align with general population data, but HCV subtypes present an atypical distribution requiring further investigation.
- * These findings highlight the need for targeted screening and management strategies for viral hepatitis in HIV patients in Morocco.
Abstract:
Human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) are major public health concerns. We aimed to determine the prevalence of HBV and HCV infections among HIV-infected patients, and to identify the main circulating hepatitis strains in Morocco. The study was carried out in 503 HIV-infected patients. Our survey indicated that the prevalence of HIV/hepatitis co-infection was 10.6%; 5.2% of patients were HBV surface antigen positive, and 5.4% of patients were anti-HCV positive. Among the HBV surface antigen-positive group, HBV DNA sequencing identified exclusively genotype D (D1: 26.7%; D7: 73.3%) in accordance with what is found in the general population. In contrast, sequencing of HCV isolates produced an unusual subtype distribution with a decreasing order of prevalence: 1a, 3a (both 23.5%), 1b, 4a (both 17.6%), 1c (11.8%) and 6h (6%).
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Retrovirus Life Cycles
Infectious Diseases and Their Occurrence
